Bone Biologics Corporation (BBLG)
USD 0.71
(-17.43%)
USD 0.71
(-17.43%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -3.02 Million USD | 59.85% |
| 2022 | -7.53 Million USD | -12.93% |
| 2021 | -6.67 Million USD | -156.94% |
| 2020 | 11.72 Million USD | 3.78% |
| 2019 | 11.29 Million USD | 40.41% |
| 2018 | 8.04 Million USD | 6.7% |
| 2017 | 7.53 Million USD | 9.87% |
| 2016 | 6.86 Million USD | 52.45% |
| 2015 | 4.5 Million USD | -3.06% |
| 2014 | 4.64 Million USD | 12.51% |
| 2013 | 4.12 Million USD | 174133813.08% |
| 2012 | -2.37 USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | -100.0% |
| 2009 | 39.77 Thousand USD | 0.0% |
| 2008 | - USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -3.22 Million USD | -6.64% |
| 2024 Q2 | -2.33 Million USD | 27.75% |
| 2023 Q3 | -4.45 Million USD | 36.46% |
| 2023 FY | -3.02 Million USD | 59.85% |
| 2023 Q1 | -6.18 Million USD | 17.91% |
| 2023 Q2 | -7 Million USD | -13.24% |
| 2023 Q4 | -3.02 Million USD | 32.03% |
| 2022 Q3 | -5.05 Million USD | 7.25% |
| 2022 Q4 | -7.53 Million USD | -49.0% |
| 2022 Q1 | -5.81 Million USD | 12.89% |
| 2022 FY | -7.53 Million USD | -12.93% |
| 2022 Q2 | -5.45 Million USD | 6.19% |
| 2021 Q4 | -6.67 Million USD | -152.3% |
| 2021 FY | -6.67 Million USD | -156.94% |
| 2021 Q2 | 12.48 Million USD | 5.37% |
| 2021 Q3 | 12.76 Million USD | 2.22% |
| 2021 Q1 | 11.85 Million USD | -2.46% |
| 2020 Q1 | 11.44 Million USD | 1.33% |
| 2020 FY | 11.72 Million USD | 3.78% |
| 2020 Q2 | 11.52 Million USD | 0.69% |
| 2020 Q3 | 11.59 Million USD | 0.63% |
| 2020 Q4 | 12.14 Million USD | 4.77% |
| 2019 Q1 | 8.97 Million USD | 11.55% |
| 2019 FY | 11.29 Million USD | 40.41% |
| 2019 Q3 | 10.99 Million USD | 4.51% |
| 2019 Q4 | 11.29 Million USD | 2.71% |
| 2019 Q2 | 10.52 Million USD | 17.27% |
| 2018 Q3 | 6.7 Million USD | -24.3% |
| 2018 FY | 8.04 Million USD | 6.7% |
| 2018 Q1 | 8.02 Million USD | 6.44% |
| 2018 Q2 | 8.85 Million USD | 10.39% |
| 2018 Q4 | 8.04 Million USD | 19.96% |
| 2017 Q3 | 8.46 Million USD | 3.14% |
| 2017 FY | 7.53 Million USD | 9.87% |
| 2017 Q4 | 7.53 Million USD | -10.97% |
| 2017 Q2 | 8.21 Million USD | 25.31% |
| 2017 Q1 | 6.55 Million USD | -4.52% |
| 2016 FY | 6.86 Million USD | 52.45% |
| 2016 Q2 | 3.45 Million USD | 212.04% |
| 2016 Q1 | 1.1 Million USD | -75.43% |
| 2016 Q4 | 6.86 Million USD | 30.07% |
| 2016 Q3 | 5.27 Million USD | 52.86% |
| 2015 FY | 4.5 Million USD | -3.06% |
| 2015 Q1 | 5.25 Million USD | 13.18% |
| 2015 Q4 | 4.5 Million USD | 35.73% |
| 2015 Q3 | 3.31 Million USD | 57.78% |
| 2015 Q2 | 2.1 Million USD | -60.0% |
| 2014 Q3 | 3.17 Million USD | -27.66% |
| 2014 FY | 4.64 Million USD | 12.51% |
| 2014 Q4 | 4.64 Million USD | 46.42% |
| 2014 Q2 | 4.38 Million USD | 284937.39% |
| 2014 Q1 | 1538.00 USD | -99.96% |
| 2013 Q3 | - USD | 100.0% |
| 2013 Q4 | 4.12 Million USD | 0.0% |
| 2013 FY | 4.12 Million USD | 174133813.08% |
| 2013 Q1 | 2370.00 USD | 604.26% |
| 2013 Q2 | -410.00 USD | -117.3% |
| 2012 Q4 | -470.00 USD | -107.76% |
| 2012 Q2 | - USD | 0.0% |
| 2012 Q3 | 6057.00 USD | 0.0% |
| 2012 FY | -2.37 USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 FY | - USD | -100.0% |
| 2010 Q4 | - USD | 0.0% |
| 2009 FY | 39.77 Thousand USD | 0.0% |
| 2009 Q4 | - USD | -100.0% |
| 2009 Q3 | 39.77 Thousand USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 Q1 | - USD | 100.0% |
| 2008 Q3 | 24.32 Thousand USD | 12.45% |
| 2008 FY | - USD | 0.0% |
| 2008 Q4 | -16.00 USD | -100.07% |
| 2008 Q1 | 27.16 Thousand USD | 136.06% |
| 2008 Q2 | 21.63 Thousand USD | -20.36% |
| 2007 Q4 | 11.5 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 27.08 Million USD | 111.176% |
| BrainsWay Ltd. | -10.32 Million USD | 70.673% |
| Cerus Corporation | 84.35 Million USD | 103.588% |
| Envoy Medical, Inc. | -3.81 Million USD | 20.646% |
| electroCore, Inc. | -9.95 Million USD | 69.597% |
| Helius Medical Technologies, Inc. | -5.12 Million USD | 40.945% |
| IceCure Medical Ltd | -9.93 Million USD | 69.533% |
| Inogen, Inc. | -103.56 Million USD | 97.078% |
| OrthoPediatrics Corp. | -9.26 Million USD | 67.34% |
| Lucid Diagnostics Inc. | -3.64 Million USD | 16.875% |
| Monogram Orthopaedics, Inc. | -13.09 Million USD | 76.891% |
| MaxCyte, Inc. | -27.76 Million USD | 89.099% |
| NeuroOne Medical Technologies Corporation | -5.13 Million USD | 41.095% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | -425.659% |
| Orthofix Medical Inc. | 96.44 Million USD | 103.138% |
| PAVmed Inc | 29.08 Million USD | 110.406% |
| Rapid Micro Biosystems, Inc. | -16.93 Million USD | 82.133% |
| RxSight, Inc. | -6.68 Million USD | 54.692% |
| Sight Sciences, Inc. | -102.71 Million USD | 97.053% |
| SI-BONE, Inc. | 5.72 Million USD | 152.903% |
| TELA Bio, Inc. | -3.94 Million USD | 23.359% |
| Treace Medical Concepts, Inc. | 57.32 Million USD | 105.28% |
| Vivos Therapeutics, Inc. | 352 Thousand USD | 959.821% |
| Acutus Medical, Inc. | 12.27 Million USD | 124.648% |
| Talis Biomedical Corporation | -57.06 Million USD | 94.696% |
| Spectral AI, Inc. | -3.5 Million USD | 13.551% |
| Nano-X Imaging Ltd. | -48.02 Million USD | 93.698% |
| CVRx, Inc. | -59.95 Million USD | 94.952% |
| DIH Holding US, Inc. Warrants | 1.98 Million USD | 252.538% |
| PetVivo Holdings, Inc. | 1.27 Million USD | 336.888% |
| Bioventus Inc. | 372.51 Million USD | 100.812% |
| Venus Concept Inc. | 74.3 Million USD | 104.073% |
| TriSalus Life Sciences, Inc. | -10.18 Million USD | 70.275% |
| LivaNova PLC | 62.53 Million USD | 104.84% |
| 908 Devices Inc. | -115.09 Million USD | 97.37% |
| Alphatec Holdings, Inc. | 320.7 Million USD | 100.944% |
| Nemaura Medical Inc. | 9.92 Million USD | 130.494% |
| NeuroPace, Inc. | 54.33 Million USD | 105.57% |
| LENSAR, Inc. | -18.31 Million USD | 83.472% |
| Apyx Medical Corporation | -5.15 Million USD | 41.243% |
| Cutera, Inc. | 288.3 Million USD | 101.05% |
| STRATA Skin Sciences, Inc. | 7.51 Million USD | 140.274% |
| BioSig Technologies, Inc. | 262 Thousand USD | 1255.179% |
| Anika Therapeutics, Inc. | -43.83 Million USD | 93.095% |
| ClearPoint Neuro, Inc. | -9.19 Million USD | 67.099% |
| Integra LifeSciences Holdings Corporation | 1.4 Billion USD | 100.215% |
| Axonics, Inc. | -77.19 Million USD | 96.079% |
| Outset Medical, Inc. | 67.67 Million USD | 104.472% |
| IRIDEX Corporation | -4.28 Million USD | 29.418% |
| PROCEPT BioRobotics Corporation | -178.01 Million USD | 98.3% |
| IRadimed Corporation | -47.71 Million USD | 93.658% |
| Tivic Health Systems, Inc. | -3.02 Million USD | -0.019% |
| INVO Bioscience, Inc. | 8.45 Million USD | 135.813% |
| Telesis Bio, Inc. | 32.63 Million USD | 109.274% |
| Viemed Healthcare, Inc. | -2.5 Million USD | -20.96% |
| Varex Imaging Corporation | 316.9 Million USD | 100.955% |
| Quipt Home Medical Corp. | 81.73 Million USD | 103.703% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | -8.791% |
| Pulmonx Corporation | -42.36 Million USD | 92.855% |
| Dynatronics Corporation | 6.2 Million USD | 148.784% |
| Modular Medical, Inc. | -8.04 Million USD | 62.365% |
| ReShape Lifesciences Inc. | -4.29 Million USD | 29.566% |
| Semler Scientific, Inc. | -57.13 Million USD | 94.702% |
| InMode Ltd. | -135.39 Million USD | 97.765% |
| Bruker Corporation | 891.3 Million USD | 100.34% |
| Cytosorbents Corporation | 4.18 Million USD | 172.371% |
| DexCom, Inc. | 2.02 Billion USD | 100.149% |
| Align Technology, Inc. | -840.47 Million USD | 99.64% |
| Viveve Medical, Inc. | -13.81 Million USD | 78.089% |
| ZimVie Inc. | 450.41 Million USD | 100.672% |
| Movano Inc. | -5.86 Million USD | 48.405% |
| Cytek Biosciences, Inc. | -134.45 Million USD | 97.749% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | -425.659% |
| DIH Holdings US, Inc. Class A Common Stock | 1.98 Million USD | 252.538% |
| Tandem Diabetes Care, Inc. | 356.79 Million USD | 100.848% |
| Profound Medical Corp. | -18.17 Million USD | 83.351% |
| Insulet Corporation | 798.1 Million USD | 100.379% |
| enVVeno Medical Corporation | -2.21 Million USD | -36.455% |
| Surmodics, Inc. | -12.01 Million USD | 74.808% |
| iCAD, Inc. | -21.2 Million USD | 85.73% |
| Nuwellis, Inc. | -2.81 Million USD | -7.363% |
| Biotricity, Inc. | 23.09 Million USD | 113.106% |
| iRhythm Technologies, Inc. | 93.65 Million USD | 103.232% |
| Aethlon Medical, Inc. | -4.5 Million USD | 32.768% |
| InspireMD, Inc. | -8.04 Million USD | 62.38% |
| PAVmed Inc. | 29.08 Million USD | 110.406% |
| BIOLASE, Inc. | 11.34 Million USD | 126.68% |
| Beyond Air, Inc. | 6.22 Million USD | 148.588% |
| FONAR Corporation | -14.66 Million USD | 79.362% |
| AxoGen, Inc. | 32.26 Million USD | 109.38% |
| Vivani Medical, Inc. | 42 Thousand USD | 7306.117% |
| Tactile Systems Technology, Inc. | -10.65 Million USD | 71.603% |
| Inari Medical, Inc. | -7.16 Million USD | 57.735% |
| UFP Technologies, Inc. | 40.77 Million USD | 107.423% |
| QT Imaging Holdings, Inc. | 3.06 Million USD | 198.63% |
| Heart Test Laboratories, Inc. | -4.77 Million USD | 36.567% |
| Tenon Medical, Inc. | -1.25 Million USD | -141.161% |
| Autonomix Medical, Inc. Common Stock | -7.6 Million USD | 60.208% |
| Co-Diagnostics, Inc. | -11.92 Million USD | 74.623% |
| AdaptHealth Corp. | 2.21 Billion USD | 100.136% |
| Sintx Technologies, Inc. | 905 Thousand USD | 434.428% |
| NanoVibronix, Inc. | -3.27 Million USD | 7.67% |
| Quanterix Corporation | -132.95 Million USD | 97.724% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | -8.791% |
| Sensus Healthcare, Inc. | -22.36 Million USD | 86.467% |
| Pacific Biosciences of California, Inc. | 753.71 Million USD | 100.402% |
| TransMedics Group, Inc. | 121.13 Million USD | 102.499% |
| ReWalk Robotics Ltd. | -26.18 Million USD | 88.439% |
| NeuroMetrix, Inc. | -1.49 Million USD | -102.98% |
| Hyperfine, Inc. | -75.61 Million USD | 95.998% |
| Establishment Labs Holdings Inc. | 152.18 Million USD | 101.989% |
| Biomerica, Inc. | -3.38 Million USD | 10.589% |
| AVITA Medical, Inc. | -26.23 Million USD | 88.462% |
| Bluejay Diagnostics, Inc. | -1.83 Million USD | -64.63% |
| Silk Road Medical, Inc | 64.42 Million USD | 104.698% |